QuatCy-I and MHI-I in Photodynamic Therapy.

ACS Med Chem Lett

Department of Chemistry, Texas A&M University, Box 30012, College Station, Texas 77842, United States.

Published: March 2022

MHI-I () and QuatCy-I () were compared in terms of properties important for early-stage photodynamic therapy preclinical candidates. Thus, experiments were performed to monitor dark cytotoxicities, light/dark cytotoxicity ratios, selectivity of localization in tumors over other organs, and clearance from the plasma.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919274PMC
http://dx.doi.org/10.1021/acsmedchemlett.1c00640DOI Listing

Publication Analysis

Top Keywords

photodynamic therapy
8
quatcy-i mhi-i
4
mhi-i photodynamic
4
therapy mhi-i
4
mhi-i quatcy-i
4
quatcy-i compared
4
compared terms
4
terms properties
4
properties early-stage
4
early-stage photodynamic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!